论文部分内容阅读
目的了解天津市和平区2010-2015年甲状腺癌流行趋势,为甲状腺癌防治策略提供依据。方法甲状腺癌病例资料来自于天津市肿瘤登记中心,计算历年甲状腺癌发病率及标化发病率,比较不同性别人群甲状腺癌的发病情况,分析甲状腺癌发病情况的年龄分布和时间趋势,并分析其病理特征。用SPSS 18.0统计软件进行统计学分析,用年度变化百分比(APC)分析率的变化趋势。结果 2010-2015年,天津市和平区登记甲状腺癌病例527例,其中男性144例,女性383例;2010-2015年年均发病率为21.70/10万(标化发病率16.57/10万),男性为12.33/10万(标化发病率为9.81/10万),女性为30.39/10万(标化发病率为22.80/10万),女性甲状腺癌发病率均高于男性,病例集中在25~59岁组(76.5%)。2010-2015年和平区甲状腺癌发病率呈上升趋势,男性APC为57.46%,女性为53.27%,合计为53.88%,有统计学意义(P<0.01)。甲状腺癌的病理类型以乳头状癌为主(82.92%)。结论和平区甲状腺癌发病水平呈明显上升趋势,应当加强甲状腺癌防控,针对甲状腺癌流行特征对重点人群进行筛查。
Objective To understand the prevalence trend of thyroid cancer in Heping District of Tianjin from 2010 to 2015 and provide evidence for the prevention and treatment of thyroid cancer. Methods The thyroid cancer data were collected from the Tumor Registry of Tianjin City. The incidence of thyroid cancer and its normalized incidence over the past years were calculated. The incidence of thyroid cancer was compared between different sexes. The age distribution and the trend of thyroid cancer incidence were analyzed and analyzed Pathological features. SPSS 18.0 statistical software for statistical analysis, the annual percentage change (APC) rate of change trend. Results A total of 527 cases of thyroid cancer were registered in Heping District of Tianjin from 2010 to 2015, including 144 males and 383 females. The average annual incidence was 21.70 / lakh (standardization rate was 16.57 / lakh) in 2010-2015, Male 12.33 / 100000 (standardized rate of 9.81 / 100000), women 30.39 / 100000 (normalized incidence of 22.80 / 100000), the incidence of thyroid cancer in women were higher than men, the cases concentrated in 25 ~ 59 years old group (76.5%). The incidence of thyroid cancer in Heping district between 2010 and 2015 showed an upward trend, with 57.46% in male and 53.27% in female, with a total of 53.88% (P <0.01). The pathological type of thyroid cancer mainly papillary carcinoma (82.92%). Conclusions The incidence of thyroid cancer in Heping district shows a rising trend. Thyroid cancer should be strengthened to prevent and control thyroid cancer. Screening of key population should be conducted according to the prevalence of thyroid cancer.